Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

438
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
438
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

379
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
379
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

816
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
816
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
Drug Dependence01:17

Drug Dependence

1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital sequelae, discharge, and early interventions in infants with Neonatal Opioid Withdrawal Syndrome.

Seminars in perinatology·2024
Same author

Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome.

JAMA network open·2024
Same author

Global Health Education in Pediatric Hospital Medicine Fellowships in the United States.

Hospital pediatrics·2024
Same author

Enhancing the health knowledge and health literacy of recently resettled refugees through classroom-based instructional methods.

Health education research·2024
Same author

NOWS or Never: Questioning the Premise of Inpatient NOWS Care.

Hospital pediatrics·2023
Same author

Early Weight Loss Percentile Curves and Feeding Practices in Opioid-Exposed Infants.

Hospital pediatrics·2022
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.4K

Neonatal Opioid Withdrawal Syndrome.

Frances Y Cheng1, Rebecca A Beagan2, Matthew R Grossman1

  • 1Department of Pediatrics, Yale University School of Medicine, Section of Hospital Medicine, 333 Cedar Street, PO Box 208064, New Haven, CT 06520, USA.

Pediatric Clinics of North America
|July 6, 2025
PubMed
Summary
This summary is machine-generated.

The eat, sleep, console approach offers an effective nonpharmacologic strategy for neonatal opioid withdrawal syndrome (NOWS). This method prioritizes environmental and parental support for improved infant outcomes.

Keywords:
Eat, Sleep, Console approachNeonatal opioid withdrawal syndromeOpioid exposure

More Related Videos

A Neonatal Mouse Spinal Cord Compression Injury Model
13:31

A Neonatal Mouse Spinal Cord Compression Injury Model

Published on: March 27, 2016

12.7K
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.4K

Related Experiment Videos

Last Updated: Sep 16, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.4K
A Neonatal Mouse Spinal Cord Compression Injury Model
13:31

A Neonatal Mouse Spinal Cord Compression Injury Model

Published on: March 27, 2016

12.7K
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.4K

Area of Science:

  • Neonatal care
  • Pharmacology
  • Public Health

Background:

  • Neonatal opioid withdrawal syndrome (NOWS) incidence has risen sharply over 20 years.
  • Traditional management relies heavily on pharmacologic interventions.
  • Emerging evidence supports nonpharmacologic approaches.

Purpose of the Study:

  • To explore updated management strategies for NOWS.
  • To highlight the eat, sleep, console (ESC) approach.
  • To emphasize comprehensive care across the continuum.

Main Methods:

  • Review of current literature on NOWS management.
  • Focus on the ESC model's components: eat, sleep, console.
  • Consideration of care from prenatal through postpartum and discharge.

Main Results:

  • The ESC approach optimizes nonpharmacologic methods like reduced stimulation and parental presence.
  • Effective NOWS management requires addressing immediate needs (withdrawal, feeding, bonding) and broader maternal care.
  • Continuous family support post-discharge is crucial.

Conclusions:

  • The ESC approach represents a significant shift towards nonpharmacologic care for NOWS.
  • Holistic, family-centered care improves outcomes for infants with NOWS.
  • Integrated prenatal, inpatient, and outpatient support is essential for NOWS management.